Cite
Transient thyrotoxicosis during nivolumab treatment
MLA
van Kooten, M. J., et al. Transient Thyrotoxicosis during Nivolumab Treatment. June 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........ba4b7ee4f24c499d0e2e8ac14e30e140&authtype=sso&custid=ns315887.
APA
van Kooten, M. J., van den Berg, G., Glaudemans, A. W. J. M., Hiltermann, T. J. N., Groen, H. J. M., Rutgers, A., & Links, T. P. (2017). Transient thyrotoxicosis during nivolumab treatment.
Chicago
van Kooten, M. J., G. van den Berg, A. W. J. M. Glaudemans, T. J. N. Hiltermann, H. J. M. Groen, A. Rutgers, and T. P. Links. 2017. “Transient Thyrotoxicosis during Nivolumab Treatment,” June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........ba4b7ee4f24c499d0e2e8ac14e30e140&authtype=sso&custid=ns315887.